These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 1972504)

  • 1. Simplified detection of Nci mutation in Gaucher disease.
    Dahl N; Lagerström M; Erikson A; Pettersson U
    Lancet; 1990 Jun; 335(8705):1589-90. PubMed ID: 1972504
    [No Abstract]   [Full Text] [Related]  

  • 2. Heterogeneity in type I Gaucher disease demonstrated by restriction mapping of the gene.
    Sorge J; Gelbart T; West C; Westwood B; Beutler E
    Proc Natl Acad Sci U S A; 1985 Aug; 82(16):5442-5. PubMed ID: 2991926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Glucocerebrosidase deficiency--Gaucher's disease].
    Tsuji S
    Tanpakushitsu Kakusan Koso; 1988 Apr; 33(5):728-33. PubMed ID: 2908399
    [No Abstract]   [Full Text] [Related]  

  • 4. Gaucher disease: retrovirus-mediated correction of the enzymatic defect in cultured cells.
    Sorge J; Kuhl W; West C; Beutler E
    Cold Spring Harb Symp Quant Biol; 1986; 51 Pt 2():1041-6. PubMed ID: 3472750
    [No Abstract]   [Full Text] [Related]  

  • 5. Gaucher disease associated with a unique KpnI restriction site: identification of the amino-acid substitution.
    Beutler E; Gelbart T
    Ann Hum Genet; 1990 May; 54(2):149-53. PubMed ID: 1974409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sequence of two alleles responsible for Gaucher disease.
    Hong CM; Ohashi T; Yu XJ; Weiler S; Barranger JA
    DNA Cell Biol; 1990 May; 9(4):233-41. PubMed ID: 1972019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic heterogeneity in type 1 Gaucher disease: multiple genotypes in Ashkenazic and non-Ashkenazic individuals.
    Tsuji S; Martin BM; Barranger JA; Stubblefield BK; LaMarca ME; Ginns EI
    Proc Natl Acad Sci U S A; 1988 Apr; 85(7):2349-52. PubMed ID: 3353383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of severity of Gaucher's disease by identification of mutations at DNA level.
    Zimran A; Sorge J; Gross E; Kubitz M; West C; Beutler E
    Lancet; 1989 Aug; 2(8659):349-52. PubMed ID: 2569551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gaucher's disease: advances and challenges.
    Martin BM; Sidransky E; Ginns EI
    Adv Pediatr; 1989; 36():277-306. PubMed ID: 2675571
    [No Abstract]   [Full Text] [Related]  

  • 10. Gaucher's disease.
    Beaudet AL
    N Engl J Med; 1987 Mar; 316(10):619-21. PubMed ID: 3807955
    [No Abstract]   [Full Text] [Related]  

  • 11. Gaucher disease type III (Norrbottnian type) is caused by a single mutation in exon 10 of the glucocerebrosidase gene.
    Dahl N; Lagerström M; Erikson A; Pettersson U
    Am J Hum Genet; 1990 Aug; 47(2):275-8. PubMed ID: 2378352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A glucocerebrosidase fusion gene in Gaucher disease. Implications for the molecular anatomy, pathogenesis, and diagnosis of this disorder.
    Zimran A; Sorge J; Gross E; Kubitz M; West C; Beutler E
    J Clin Invest; 1990 Jan; 85(1):219-22. PubMed ID: 2295698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genotype assignment in Gaucher disease by selective amplification of the active glucocerebrosidase gene.
    Firon N; Eyal N; Kolodny EH; Horowitz M
    Am J Hum Genet; 1990 Mar; 46(3):527-32. PubMed ID: 2309702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retrovirus-mediated transfer of the human glucocerebrosidase gene to Gaucher fibroblasts.
    Choudary PV; Barranger JA; Tsuji S; Mayor J; LaMarca ME; Cepko CL; Mulligan RC; Ginns EI
    Mol Biol Med; 1986 Jun; 3(3):293-9. PubMed ID: 3736391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic heterogeneity in Gaucher disease.
    Zlotogora J; Zaizov R; Klibansky C; Matoth Y; Bach G; Cohen T
    J Med Genet; 1986 Aug; 23(4):319-22. PubMed ID: 3746831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The human glucocerebrosidase gene has two functional ATG initiator codons.
    Sorge JA; West C; Kuhl W; Treger L; Beutler E
    Am J Hum Genet; 1987 Dec; 41(6):1016-24. PubMed ID: 3687939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutations of glucocerebrosidase: discrimination of neurologic and non-neurologic phenotypes of Gaucher disease.
    Ginns EI; Brady RO; Pirruccello S; Moore C; Sorrell S; Furbish FS; Murray GJ; Tager J; Barranger JA
    Proc Natl Acad Sci U S A; 1982 Sep; 79(18):5607-10. PubMed ID: 6957882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunological and catalytic quantitation of splenic glucocerebrosidase from the three clinical forms of Gaucher disease.
    Pentchev PG; Neumeyer B; Svennerholm L; Groth CG; Brady RO
    Am J Hum Genet; 1983 Jul; 35(4):621-8. PubMed ID: 6881138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucocerebrosidase "processing" and gene expression in various forms of Gaucher disease.
    Beutler E; Kuhl W; Sorge J
    Am J Hum Genet; 1985 Nov; 37(6):1062-70. PubMed ID: 4083278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene mapping and leader polypeptide sequence of human glucocerebrosidase: implications for Gaucher disease.
    Ginns EI; Choudary PV; Tsuji S; Martin B; Stubblefield B; Sawyer J; Hozier J; Barranger JA
    Proc Natl Acad Sci U S A; 1985 Oct; 82(20):7101-5. PubMed ID: 3863141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.